NALFON Drug Patent Profile
✉ Email this page to a colleague
When do Nalfon patents expire, and when can generic versions of Nalfon launch?
Nalfon is a drug marketed by Xspire Pharma and Dista and is included in two NDAs.
The generic ingredient in NALFON is fenoprofen calcium. There are nine drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the fenoprofen calcium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nalfon
A generic version of NALFON was approved as fenoprofen calcium by XSPIRE PHARMA on August 17th, 1988.
Summary for NALFON
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 97 |
Patent Applications: | 3,894 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for NALFON |
What excipients (inactive ingredients) are in NALFON? | NALFON excipients list |
DailyMed Link: | NALFON at DailyMed |
Pharmacology for NALFON
Drug Class | Nonsteroidal Anti-inflammatory Drug |
Mechanism of Action | Cyclooxygenase Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for NALFON
US Patents and Regulatory Information for NALFON
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Xspire Pharma | NALFON | fenoprofen calcium | CAPSULE;ORAL | 017604-003 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Dista | NALFON | fenoprofen calcium | TABLET;ORAL | 017710-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Xspire Pharma | NALFON | fenoprofen calcium | CAPSULE;ORAL | 017604-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Xspire Pharma | NALFON | fenoprofen calcium | CAPSULE;ORAL | 017604-004 | Jul 21, 2009 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for NALFON
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Xspire Pharma | NALFON | fenoprofen calcium | CAPSULE;ORAL | 017604-003 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
Xspire Pharma | NALFON | fenoprofen calcium | CAPSULE;ORAL | 017604-002 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
Dista | NALFON | fenoprofen calcium | TABLET;ORAL | 017710-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for NALFON
See the table below for patents covering NALFON around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Finland | 63928 | ⤷ Try a Trial | |
Finland | 54099 | ⤷ Try a Trial | |
Netherlands | 165147 | ⤷ Try a Trial | |
Finland | 57592 | ⤷ Try a Trial | |
Denmark | 240677 | ⤷ Try a Trial | |
Norway | 773495 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |